Aspartame, a bittersweet pill

Area of Science:

• Toxicology
• Food Science
• Regulatory Affairs

Background:

• Corporations are increasingly influenced by public opinion regarding food additives.
• Regulatory agencies assure the safety of artificial ingredients like aspartame.
• Cesare Maltoni Cancer Research Center of the Ramazzini Institute (CMCRC/RI) has published studies on aspartame's carcinogenicity.

Purpose of the Study:

• To analyze PepsiCo's decision to remove aspartame from its products.
• To examine the role of public opinion and scientific studies in corporate decisions.
• To discuss the implications for regulatory guidelines and consumer trust.

Main Methods:

• Analysis of PepsiCo's decision-making process.
• Review of CMCRC/RI life-span carcinogenicity bioassay studies on aspartame.
• Examination of criticisms regarding OECD guidelines for carcinogenicity testing.

Main Results:

• PepsiCo's unprecedented decision to ban aspartame, likely influenced by CMCRC/RI studies.
• CMCRC/RI studies provide consistent evidence of aspartame's carcinogenicity in rodents.
• Potential for other corporations to follow suit, impacting the artificial ingredient market.

Conclusions:

• Corporate decisions on artificial ingredients are increasingly swayed by public opinion and scientific evidence, even when regulatory assurances exist.
• Existing regulatory guidelines (OECD) may require re-evaluation in light of new scientific findings and public perception.
• The credibility of international regulatory agencies is at stake if they fail to address public concerns and evolving scientific evidence.